The Massachusetts ADRC, Harvard NeuroDiscovery Center and the MGH Neurology Clinical Trials Unit have joined forces to fund the best novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including the affiliated hospitals and institutions. In addition, investigators from the University of Massachusetts community are encouraged to submit ALS-related purposals.
The Harvard NeuroDiscovery Center (www.neurodiscovery.harvard.edu) is pleased to announce the 2nd year of a major funding opportunity for collaborative basic neuroscience research across the Harvard and MIT communities. Up to 5 $200,000 grants ($100,000 per year for 2 years) may be awarded each year.
The deadline for this year's application is September 1, 2011.
Please refer to the attached documents for more specific details.
The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia-specified biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
The Massachusetts Alzheimer's Disease Research Center (ADRC) has an opening for a two-year Clinical Research Fellowship in Alzheimer's disease (AD) and related disorders at the Massachusetts General Hospital (MGH) and Brigham & Women's Hosptial (BWH) beginning July 1, 2012.
The Massachusetts General Hospital (MGH)'s Multicultural Affairs Office and the Executive Committee on Research are inviting faculty and physicians pursuing an academic career as clinicians, teachers, community and/or administrative leaders to apply for its 2011Clinican-Teacher Development Award designed for MDs and/or PhDs at MGH who are under-represented in academic medicine.
The Massachusetts General Hospital (MGH)'s Multicultural Affairs Office and the Executive Committee on Research are inviting basic, clinical, translational and health services investigators to apply for its 2011 Physician-Scientist Development Award designed for MD and/or PhD investigators at MGH who are under-represented in academic medicine.
New proposals or initiatives for biomedical, epidemiological, behavioral, legal, ethical, health systems or other research in Alzheimer's disease are encouraged. Two NIH-funded proposals for $25,000 in direct costs for 1-year, non-renewable studies will be awarded.
The Fondation De Cooperation Scientifique Pour La Recherche Sur La Maladie D'Alzheimer & Les Maladies Apparentees (www.fondation-alzheimer.org) has issue a Call for Senior Innovative Team applications from investigators who have strong backgrounds in Alzheimer's disease and related disorders to apply for a grant from the Fondation. The grant will offer a five-year salary for the Principal Investigator, two additional salaries for co-applicants, and a budget for consumables and supplies.
The Fondation De Cooperation Scientifique Pour La Recherche Sur La Maladie D'Alzheimer & Les Maladies Apparentees (www.fondation-alzheimer.org) has issue a Call for Junior Researchers who have post-doctoral experiences to apply for a grant from the Fondation. The grant will offer a three-year salary that could be extended for two supplemental years.
Are you a researcher with an interest in the area of late-life depression? On February 17, 2011, join a new working group at Harvard Medical School and its affiliated institutions to address gaps in research on geriatric depression for a full-day workshop called LaUNCH, which would include presentations by distinguished investigators and guest speakers.
The Working Group will focus on four different research tracks:
1. Biomarkers and emerging translational tools
2. Measurement, including refinements for diverse populations